Boston Scientific Announces 2021 Investor Day Meeting
Company leaders will present long-range strategy and financial goals in addition to market overviews and pipeline updates

MARLBOROUGH, Mass., Sept. 9, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will host a meeting with the investor community to review its financial goals and long-term growth strategies on Wednesday, September 22, 2021, from 8:30 a.m.12:30 p.m. EDT. Company leaders will also provide business unit market overviews, pipeline updates and spotlight key products from the company's Cardiovascular, MedSurg and Rhythm and Neuro segments.

The meeting will be held in hybrid format, live in Boston as well as a simultaneous webcast. Investors and other interested parties may register for the live meeting or webcast by visiting the events and presentations section on the company's investor website at http://investors.bostonscientific.com.  A replay and summary materials from the presentations will also be available online for approximately one year following the event. 

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS


Media:                                                                      

Investors:

Kate Haranis                                                          

Lauren Tengler

508-683-6585 (office)                                           

508-683-4479 (office)

Media Relations                                                    

Investor Relations

Boston Scientific Corporation                             

Boston Scientific Corporation

Kate.Haranis@bsci.com                                           

BSXInvestorRelations@bsci.com

 

SOURCE Boston Scientific Corporation

Top